L04AX05 · Antineoplastic and immunomodulating agents
Pirfenidone Viatris
Indications
Pirfenidone Viatris is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF).
Composition
- Active substance
- Pirfenidone
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Pirfenidone Viatris
- Active substance
- Pirfenidone
- ATC code
- L04AX05
- Therapeutic area
- Idiopathic Pulmonary Fibrosis, Lung Diseases, Respiratory Tract Diseases
- Marketing authorisation holder
- Viatris Limited
- Status
- Authorised